Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)

China flag China · Delayed Price · Currency is CNY
10.52
+1.03 (10.85%)
Apr 29, 2026, 3:04 PM CST
19.41%
Market Cap 3.78B
Revenue (ttm) 1.45B
Net Income (ttm) -30.75M
Shares Out 398.52M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE n/a
Dividend 0.20 (2.11%)
Ex-Dividend Date n/a
Volume 29,427,787
Average Volume 6,104,821
Open 9.43
Previous Close 9.49
Day's Range 9.43 - 10.77
52-Week Range 8.73 - 14.55
Beta 0.60
RSI 61.61
Earnings Date Apr 29, 2026

About SHE:301060

Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing; and professional technical support services. In addition, the company offers rental, business, and human resources services. Further, it operates Lan... [Read more]

Sector Healthcare
Founded 1993
Employees 1,365
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301060
Full Company Profile

Financial Performance

In 2025, SHE:301060's revenue was 1.45 billion, a decrease of -16.88% compared to the previous year's 1.74 billion. Losses were -30.75 million, -71.90% less than in 2024.

Financial Statements

News

There is no news available yet.